Skip to content

P AMY AY3855Recalls & reported problems

Randox Laboratories Limited · A Pancreatic α‑Amylase test system is a device intended for the quantitative in vitro determination of Pancreatic α‑Amylase activity in serum, plasma or urine. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Recalls naming this device

  1. Jul 10, 2020Terminated

    Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020.

    Z-2924-2020 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Other Catalytic Methods, Amylase devices

All Catalytic Methods, Amylase devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page